💊

Thiotepa Riemser

thiotepa

Hämatopoetische Stammzelltransplantation;Neoplasien

✅ Autorisiert Generisch

✅

Keine aktiven Warnungen

Dieses Arzneimittel unterliegt derzeit keinen Lieferengpässen, Sicherheitshinweisen oder Rückrufen.

Wofür es verwendet wird

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Patientensicherheit

Offizielle EMA-Seite

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser